Outstanding measure of efficacy relative to high-risk cancers with limited treatment optionsCHICAGO, (GLOBE NEWSWIRE) -- MAIA ...

Secarna Pharma inks agreement with Scenic Biotech to discover and co-develop disease-modifying oligonucleotide therapy against a novel drug target: Munich, Germany Saturday, Octob ...

Inflarx N.V. (($IFRX)) announced an update on their ongoing clinical study. Study Overview: The JUST BREATHE study, ...

First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, (GLOBE ...

Lady Purple was awarded Gold during the latest Pure Beauty Awards 2025 as the Best New Ingredient. This article dives deep ...

Patients gain hope through regenerative medicine doctors earn empowerment and recognition and India gains economic momentum through reduced chronic burden and enhanced GDP growth.Dr. Polisetty ...

Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Com ...

BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, t ...

When ultra-rich investors start coalescing into the same names or put an unusually large amount of money into a single stock, ...

Alps Group Inc (the “ Company ” or “ Alps Group ”), the parent company of Alps Life Sciences Inc. (“ Alps Holdco ”), a fully integrated biotechnology research and healthcare platform specializing in ...